# The Use of Urinary Dickkopf 3 (u DKK3) as a New Biomarker Which Can Identify Patients at High Risk of Renal Allograft Dysfunction, Earlier That the Current Established Tests.

> **NCT07176806** · — · NOT_YET_RECRUITING · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 258 (estimated)

## Conditions studied

- Renal Transplant Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07176806
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01
- **Primary completion:** 2026-07
- **Final completion:** 2027-01
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07176806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07176806, "The Use of Urinary Dickkopf 3 (u DKK3) as a New Biomarker Which Can Identify Patients at High Risk of Renal Allograft Dysfunction, Earlier That the Current Established Tests.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07176806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
